GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GeNeuro SA (FRA:GEM) » Definitions » Long-Term Debt

GeNeuro (FRA:GEM) Long-Term Debt : €12.12 Mil (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is GeNeuro Long-Term Debt?

GeNeuro's Long-Term Debt for the quarter that ended in Dec. 2023 was €12.12 Mil.

GeNeuro's quarterly Long-Term Debt increased from Dec. 2022 (€5.65 Mil) to Jun. 2023 (€11.51 Mil) and increased from Jun. 2023 (€11.51 Mil) to Dec. 2023 (€12.12 Mil).

GeNeuro's annual Long-Term Debt increased from Dec. 2021 (€2.54 Mil) to Dec. 2022 (€5.65 Mil) and increased from Dec. 2022 (€5.65 Mil) to Dec. 2023 (€12.12 Mil).

GeNeuro Long-Term Debt Historical Data

The historical data trend for GeNeuro's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GeNeuro Long-Term Debt Chart

GeNeuro Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 2.54 5.65 12.12

GeNeuro Semi-Annual Data
Dec13 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.54 3.41 5.65 11.51 12.12

GeNeuro  (FRA:GEM) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

GeNeuro Long-Term Debt Related Terms

Thank you for viewing the detailed overview of GeNeuro's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

GeNeuro Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GeNeuro SA (FRA:GEM) » Definitions » Long-Term Debt
Comparable Companies
XPAR:ALMDP XPAR:ALBPS XPAR:ALTHX XPAR:ALINT XPAR:ALNEV XPAR:ALTME XPAR:ALOPM XPAR:ALTAO XPAR:ALVET XPAR:ALVIO VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
3 chemin du Pre-Fleur, Plan-les-Ouates, Geneva, CHE, 1228
Website
https://www.geneuro.com
GeNeuro SA is a clinical-stage biopharmaceutical company focused on understanding and stopping causal factors driving the progression of neurodegenerative and autoimmune diseases. The company's therapeutic candidate, temelimab, is a humanized monoclonal antibody that neutralizes a pathogenic protein of the HERV-W family (W-ENV).